NLS Pharmaceutics Financial Ratios for Analysis 2019-2024 | NLSP

Fifteen years of historical annual and quarterly financial ratios and margins for NLS Pharmaceutics (NLSP).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022202120202019
0.232.752.380.030.09
----0.04-0.03
-0.18---0.23-0.14
-----
-----
-----
-----
-----
-----
-----
-----
-----
-----
138-502.79-2,202.5131.8588.27
138-502.79-2,202.5031.8588.27
-659.14-177.82-207.23-236.17-782.15
138-502.79-2,202.5033.0090.50
-10.904.051.34-51.63-35.47
-10.15-28.21-50.20-4.19-1.11
-10.15-28.21-50.33-4.19-1.11

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2023-12-312023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312019-12-31
--------
--------
--------
--------
--------
--------
--------
--------
--------
--------
--------
--------
--------
--------
--------
--------
--------
--------
0.000.000.000.000.000.000.000.00
--------